期刊文献+

核受体与脂质代谢 被引量:4

Nuclear receptors and lipid metabolism
原文传递
导出
摘要 核受体是配体活化的转录因子,能调控大量的靶基因。近年来核受体调节脂质代谢的研究已成为国内外研究的热点。由于核受体在调节脂质代谢、糖代谢以及炎症反应方面发挥重要作用,它们是治疗心血管疾病理想的靶标。本文简要地介绍了核受体在调节脂质代谢方面的研究进展。 Nuclear receptors (NRs) are ligand-activated transcription factors that regulate the activation of a variety of important target genes. Recently, studies focusing on the regulation of lipid metabolism by nuclear receptors have gained increasing attention home and abroad. As NRs play major roles in the regulation of lipid metabolism, glucose homeostasis, and inflammatory processes, they are considered as ideal targets for the treatment of cardiovascular diseases. This paper briefly reviews the researches on the regulation of lipid metabolism by nuclear receptors.
出处 《生命科学》 CSCD 北大核心 2009年第3期425-429,共5页 Chinese Bulletin of Life Sciences
关键词 胆汁酸 胆固醇 核受体 脂肪酸 动脉粥样硬化 bile acid cholesterol nuclear receptors fatty acid atherosclerosis
  • 相关文献

参考文献31

  • 1Hong C, Tontonoz P. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Ctttr Opin Genet Dev, 2008, 18(5): 461-7
  • 2Mastsuura F, Hirano KI, Ikegami C, et al. Senescent phenotypes of skin fibroblasts from patients with Tangier disease. Biochem Biophys Res Commun, 2007, 357(2): 493-8
  • 3Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab, 2005, 1 (2): 121-31
  • 4Tangirala RK, Bischoff ED, Joseph SB, et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA, 2002, 99(18): 11896-901
  • 5Peng D, Hiipakka RA, Reardon CA, et al. Differential antiatherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis, 2009, 203(1): 59-66
  • 6Hu B, Collini M, Unwalla R, et al. Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis. J Med Chem, 2006, 49(21): 6151-4
  • 7Peng D, Hiipakka RA, Dai Q, et al. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low density lipoprotein receptor-deftcient mice. J Pharmacol Exp Ther, 2008, 327(2): 332-42
  • 8Kratzer A, Buchebner M, Pfeifer T, et al. Synthetic LXR agonist attenuates plaque formation in apoE-deficient mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res, 2009, 50(2): 312-26
  • 9Qin Y, Dalen KT, Gustafsson JA, et al. Regulation of hepatic fatty acid elongase 5 by LXRα-SREBP-1c. Biochim Biophys Acta, 2009, 1791(2): 140-7
  • 10Lund EG, Peterson LB, Adams AD, et al. Different roles of liver X receptor α and β in lipid metabolism: Effects of an α- selective and a dual agonist in mice deficient in each subtype. Biochem Pharmacol, 2006, 71(4): 453-63

同被引文献28

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部